Lyell Immunopharma Inc (LYEL) — Cash Flow Reinvestment Rate
Lyell Immunopharma Inc (LYEL) has a Cash Flow Reinvestment Rate of 10.70x as of December 2019, reinvesting $422.43 Million (capex $16.05 Million plus investments $-406.39 Million) from operating cash flow of $39.47 Million. Explore LYEL capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Lyell Immunopharma Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Lyell Immunopharma Inc across 1 annual periods. Also explore Lyell Immunopharma Inc (LYEL) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Lyell Immunopharma Inc (2019–2019)
Year-by-year capital reinvestment analysis for Lyell Immunopharma Inc. For live market cap and broader valuation context, see LYEL company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 10.70x | $422.43 Million | $39.47 Million | $16.05 Million | — |